Colgate-Palmolive stock falls as Piper Sandler cuts target
📉 Piper Sandler cut Colgate-Palmolive's price target from USD 98 to USD 95 due to concerns over soft consumer demand.
⚠️ Analysts highlighted stronger competition in the North American market as a key risk factor for the company.
💰 Q1 2026 revenue reached USD 5.32 billion, beating the consensus estimate of USD 5.22 billion by USD 0.10 billion.
📊 Earnings per share for Q1 2026 were USD 0.97, exceeding the analyst consensus of USD 0.94.
🔮 Piper Sandler maintained its 2026 EPS estimate at USD 3.85 but lowered the 2027 forecast to USD 4.12.
📈 The stock closed at USD 87.47, trading 11.9 percent below its 52-week high of USD 99.33.
💼 Colgate-Palmolive's market capitalization stood near USD 69.99 billion as of September 21, 2026.
- Colgate-Palmolive reported Q1 2026 revenue of USD 5.32 billion, which exceeded the analyst consensus estimate of USD 5.22 billion by USD 0.10 billion.
- The company delivered earnings per share of USD 0.97 in Q1 2026, surpassing the market consensus expectation of USD 0.94.
- Piper Sandler reduced its price target from USD 98 to USD 95, citing soft consumer demand as a primary concern.
- Analysts identified stronger competition in the North American market as a significant headwind impacting the company's outlook.
- Piper Sandler lowered its 2027 EPS estimate to USD 4.12 from USD 4.23, indicating reduced long-term growth expectations.